Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.

After nearly 18 years on medication to manage her high blood pressure, Charity Wischmeyer, 51, is now discussing with her ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

In the early days of the semaglutide weight loss wave, many of its users reported less interest in alcohol. A study now says ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis ...

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...